Effects of acute and chronic administration of phencyclidine on the A10 dopaminergic mesolimbic system: electrophysiological and behavioral correlates.
Electrophysiological and behavioral methods were used to evaluate the effects of chronic exposure to phencyclidine (PCP, 5 mg/kg/day for 30 days) on ventral tegmental A10 dopaminergic neurons and locomotor and ataxic behavior in the rat. Extracellular recordings from single neurons in the ventral tegmentum showed only minimal differences between rats chronically treated with either saline or PCP. A comparison of the rising portion of the cumulative dose-response curves indicated that the animals treated chronically with the drug required only 0.4 times more PCP than the controls to produce equivalent changes in neuronal firing rates. Also, the average maximum increase in activity in A10 neurons, induced by PCP, was 43% in the drug-treated rats compared to 60% in the controls. Although these were moderate quantitative changes, a marked qualitative difference in the response of A10 neurons to PCP was seen. Whereas PCP elicited a characteristic dose-dependent biphasic effect on the firing rates in the control group, the declining (inhibitory) component of the response was not present in the animals chronically treated with PCP. In parallel with the minimal electrophysiological changes, measurements of gross locomotor activity showed that the response to the thirtieth (30th) injection of PCP was virtually identical to that measured in the same animals following the first exposure. In contrast, however, the ataxia which accompanied the hyperactivity rapidly diminished over the course of treatment. It would appear, therefore, that chronic exposure to PCP did not substantially diminish the ability of PCP to activate the A10 neurons, comprising the mesocorticolimbic dopaminergic systems.(ABSTRACT TRUNCATED AT 250 WORDS)
French
E D
ED
Maryland Psychiatric Research Center, University of Maryland, Baltimore 21228.
D000818:Animals; D001259:Ataxia / Q000139:chemically induced; D001522:Behavior, Animal / Q000187:drug effects*; D004298:Dopamine / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D004594:Electrophysiology; D008032:Limbic System / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D010622:Phencyclidine / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D013997:Time Factors
D010622:Phencyclidine; D004298:Dopamine